Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell Growth

Xu, B; Muramatsu, T; Inazawa, J

Muramatsu, T (corresponding author), Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan.; Muramatsu, T (corresponding author), Tokyo Med & Dent Univ TMDU, Med Res Inst, Lab Integrated Res Projects Intractable Dis, Tokyo, Japan.; Inazawa, J (corresponding author), Tokyo Med & Dent Univ TMDU, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.

MOLECULAR CANCER RESEARCH, 2021; 19 (4): 585

Abstract

Despite increasing knowledge on oral and esophageal squamous cell carcinoma (OSCC and ESCC), specific medicines against both have not yet been develop......

Full Text Link